SEC Comment Letter for PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Dec 26, 2024
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: Dec. 26, 2024 · CIK: 0001624326 · Accession: 0000000000-24-014272
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283994
Letter
December 26, 2024 Lishan Aklog, M.D. Chairman of the Board and Chief Executive Officer PAVmed Inc. 360 Madison Avenue, 25th Floor New York, NY 10017 Re:PAVmed Inc. Registration Statement on Form S-3 Filed December 20, 2024 File No. 333-283994 Dear Lishan Aklog M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Juan Grana at 202-551-6034 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Jeffrey M. Gallant, Esq.
Show Raw Text
December 26, 2024
Lishan Aklog, M.D.
Chairman of the Board and Chief Executive Officer
PAVmed Inc.
360 Madison Avenue, 25th Floor
New York, NY 10017
Re:PAVmed Inc.
Registration Statement on Form S-3
Filed December 20, 2024
File No. 333-283994
Dear Lishan Aklog M.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Juan Grana at 202-551-6034 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Jeffrey M. Gallant, Esq.